ARS Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Trade ARS Pharmaceuticals 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About SPRY
ARS Pharmaceuticals, Inc. is a biopharmaceutical company, which focuses on the development of a novel, potentially first-in-class product candidate, neffy, for the emergency treatment of Type I allergic reactions including anaphylaxis. Its product includes Epinephrine Nasal Spray.
CEORichard E. Lowenthal
CEORichard E. Lowenthal
Employees160
Employees160
HeadquartersSan Diego, California
HeadquartersSan Diego, California
Founded2015
Founded2015
Employees160
Employees160
SPRY Key Statistics
Market cap1.34B
Market cap1.34B
Price-Earnings ratio-83.59
Price-Earnings ratio-83.59
Dividend yield—
Dividend yield—
Average volume1.66M
Average volume1.66M
High today$13.77
High today$13.77
Low today$12.19
Low today$12.19
Open price$12.41
Open price$12.41
Volume2.21M
Volume2.21M
52 Week high$18.51
52 Week high$18.51
52 Week low$7.55
52 Week low$7.55
Analyst ratings
100%
of 6 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own SPRY. This list is generated using Robinhood data, and it’s not a recommendation.